Announcements

Intimation about completion of 1,00,000 COVID-19 RT PCR tests in 108 days by Thyrocare at affordable cost and at minimum possible time in accordance with the relevant regulations, guidelines and instructions issued by ICMR from time to time. Also to note that the Company has started testing for COVID Antibodies from 28.06.2020 and have done more than 25,000 tests within a short span of 10 days.View Here

Intimation that Trading Window shall remain closed for Directors, Designated Employees and Connected Persons with effect from 1^st July, 2020 and will be reopened after 48 hours of date of announcement / declaration of Unaudited Financial Results for the Quarter ended June 30, 2020.

Intimation of decisions taken at the Board Meeting held on May 23, 2020, about i) approval of the Audited Financial Statements (both Stand-alone and Consolidated) for the quarter and the whole year ended 31-03-2020, ii) deferring recommendation of final dividend for the FY 2019-20, and iii) granting of Stock Options to the eligible employees for FY 2019-20.

Intimation about Board Meeting scheduled to be held on Saturday, May 23, 2020, inter alia, to consider and approve the audited financial results (both Stand-alone and Consolidated) for the year ended 31st March 2020, to consider recommending final dividend, if any, for the financial year 2019-20, and to consider granting of stock options to employees for 2019-20.

Intimation about closure of Trading Window for Directors, Employees and Connected Persons from April 01, 2020 (as already announced) up to end of the day on May 26, 2020.

Intimation that Trading Window shall remain closed for Directors, Designated Employees and Connected Persons with effect from 1^st April, 2020 and will be reopened after 48 hours of date of announcement / declaration of Audited Financial Results for the Quarter and Year ended March 31, 2020.

Intimation about the con-calls with the representatives of the following organisations to discuss the impact of COVID-19:

(i) ICICI Prudential AMC, at 02.30 P.M. on Tuesday, March 31, 2020.

(ii) Premji Invest, at 03.30 P.M. on Tuesday, March 31, 2020.

(iii) Nippon India Mutual Fund, at 04.00 P.M. on Wednesday, April 01, 2020.

Intimation about Con-call arranged by PhillipCapital (India) Pvt. Ltd. with Dr. A. Velumani, Chairman, Managing Director and CEO of our company, to discuss on ‘Covid-19 and its impact on Indian Healthcare’, at 02.30 P.M. today, i.e. Wednesday, March 18, 2020, and deferring of Con-call arranged through Prabhudas Lilladher Pvt. Ltd. on the same topic.

Intimation about Con-call through Prabhudas Lilladher (P) Limited, on ‘Covid-19 and Diagnostics’, at 04.00 P.M., today i.e. Wednesday, March 18, 2020.

Intimation about meeting of representative(s) of Crescita Investment Management Pvt. Ltd. with us at 04.00 P.M. on Wednesday, March 11, 2020 at the Corporate Office of the Company.

Intimation about the following forthcoming Analyst meetings:

(i) Meeting with the representative(s) of J. P. Morgan India Private Limited, at 11.30 A.M. on Wednesday, March 11, 2020.

(ii) Meeting with the representative(s) of Aditya Birla Capital, at 11.00 A.M. on Thursday, March 12, 2020.

(iii) Meeting with the representative(s) of Hill Fort Capital Partners Limited, at 11.30 A.M. on Wednesday, March 18, 2020.

Intimation about the following forthcoming Analyst meetings:

(i) Meeting with the representative(s) of QRC Investment Advisors LLP, at 11.30 A.M. on Monday, February 24, 2020.

(ii) Meeting with the representative(s) of SBI Mutual Fund, at 3.00 P.M. on Monday, February 24, 2020.

(iii) Meeting with the representative(s) of Ampersand Capital Partners, at 11.30 A.M. on Tuesday, February 25, 2020.

(iv) Meeting with the representative(s) of Wallfort Financial Services Limited, at 4.00 P.M. on Tuesday, February 25, 2020.

Press Release – Launching of marketing Joint Venture by Thyrocare for Datar Cancer Genetics, for early detection of 16 types of cancer.View Here

Intimation about the following forthcoming Con-call:

(i) Con-call with the representative(s) of Eternity Capital Management Limited, at 11.00 A.M. on Monday, February 17, 2020.

(ii) Con-call with the representative(s) of Mirabilis Investment Trust, at 04.00 P.M. on Monday, February 17, 2020.

Update about closure of two centres (Surat and Baroda) of Nueclear Healthcare Limited, wholly owned subsidiary of the Company.

Intimation of decisions taken at the Board Meeting held on February 01, 2020, about (i) approval of the Unaudited Financial Results (both Stand-alone and Consolidated) for the quarter / nine months ended on 31-12-2019, (ii) deferring of further dividend to the next Meeting, (iii) reappointment of Dr. A. Velumani as Managing Director & Chief Executive Officer for a further period of five years, and (iv) reappointment of Mr. A. Sundararaju as Executive Director & Chief Financial Officer for a further period of five years.

Intimation about Board Meeting scheduled to be held on Saturday, February 01, 2020 to inter alia, consider and approve the Unaudited financial results (both Stand-alone and Consolidated) for the quarter / nine months ended December 31, 2019, payment of further interim dividend, if any, and reappointment of Dr. A. Velumani as Managing Director & CEO and Mr. A. Sundararaju as Executive Director & CFO.

Intimation that Trading Window shall remain closed for Directors, Designated Employees and Connected Persons with effect from 1^st January 2020 and will be reopened after 48 hours of date of announcement / declaration of Unaudited Financial Results for the Quarter /Nine months ended December 31, 2019.

Intimation that the Company has allotted 37,759 numbers of equity shares to 103 eligible employees of the Company, who have exercised the Options granted to them under ESOP Scheme 2016.

Intimation about meeting of representative(s) of Sundaram Asset Management Company Limited, with us at 10.30 A.M. on Saturday, December 14, 2019 at the Corporate Office of the Company.

Intimation about the following forthcoming Analyst meetings:

(i) Meeting with the representative(s) of Banyan Capital Advisors LLP, at 11.30 A.M. on Monday, December 09, 2019.

(ii) Meeting with the representative(s) of PhillipCapital (India) Pvt. Ltd., at 03.30 P.M. on Wednesday, December 11, 2019.

(iii) Meeting with the representative(s) of Arisaig Partners, at 11.00 A.M. on Monday, December 16, 2019.

(iv) Meeting with the representative(s) of Spark Capital Advisors (I) Pvt. Ltd., at 11.00 A.M. on Tuesday, December 17, 2019, to be followed by a visit by them to our lab.

Intimation about the following forthcoming Con-call / Analyst meeting:

(i) Con-call with the representative(s) of Nippon India Mutual Fund, at 04.00 P.M. on Tuesday, December 03, 2019.

(ii) Meeting with the representative(s) of ADD Capital, at 03.30 P.M. on Wednesday, December 04, 2019, at the Corporate Office of the Company.

Intimation about meeting of representative(s) of InvesQ Investment Advisors, with us at 11.00 A.M. on Friday, November 29, 2019 at the Corporate Office of the Company.

Intimation about the following forthcoming Con-call / Analyst meeting:

(i) Con-call with the representative(s) of Eternity Capital Management Limited, at 11.30 A.M. on Monday, November 25, 2019.

(ii) Meeting with the representative(s) of Capital Investment Research Services Private Limited (Capital Group), at 10.30 A.M. on Monday, December 02, 2019, at the Corporate Office of the Company.

Intimation about the following forthcoming Con-call / Analyst meeting:

(i) Con-call with the representative(s) of Bajaj Allianz, Pune, at 04.00 P.M. on Thursday, November 21, 2019.

(ii) Meeting with the representative(s) of Vishuddha Capital Management, at 03.00 P.M. on Friday, November 22, 2019, at the Corporate Office of the Company.

Intimation of decisions taken at the Board Meeting held on November 07, 2019, about approval of the Unaudited Financial Results (both Stand-alone and Consolidated) for the quarter / half year ended on 30-09-2019 and declaration of interim dividend of Rs.5/- per share for FY 2019-20, and fixing of Friday, November 22, 2019 as the Record Date for this purpose.

Intimation about Board Meeting scheduled to be held on Thursday, November 07, 2019 to inter alia, consider and approve the Unaudited financial results (both Stand-alone and Consolidated) for the quarter / half year ended September 30, 2019, and to consider payment of interim dividend, if any.

Intimation that  the representative(s) of Capital Investment Research Services Private Limited would be having a Con-call with us by 05.30 P.M. on Friday, October 04, 2019.

Intimation that Trading Window shall remain closed for Directors, Designated Employees and Connected Persons with effect from 1^st October 2019 and will be reopened after 48 hours of date of announcement / declaration of Unaudited Financial Results for the Quarter /Half-year ended September 30, 2019.

Intimation about the following forthcoming meeting / Con-call:

(i) Con-call with the representative(s) of Sundaram Asset Management Company Limited, at 10.30 A.M. on Monday, September 30, 2019.

(ii) Meeting with the representative(s) of Fundsmith LLP, at 2.30 P.M. on Tuesday, October 01, 2019.